cd30l Search Results


92
Sino Biological cd30l fc recombinant protein
The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of <t>CD30L</t> isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.
Cd30l Fc Recombinant Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd30l fc recombinant protein/product/Sino Biological
Average 92 stars, based on 1 article reviews
cd30l fc recombinant protein - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

90
Miltenyi Biotec pe anti cd153 ab rm153
The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of <t>CD30L</t> isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.
Pe Anti Cd153 Ab Rm153, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pe anti cd153 ab rm153/product/Miltenyi Biotec
Average 90 stars, based on 1 article reviews
pe anti cd153 ab rm153 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

94
OriGene rc211276 rc231923
The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of <t>CD30L</t> isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.
Rc211276 Rc231923, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rc211276 rc231923/product/OriGene
Average 94 stars, based on 1 article reviews
rc211276 rc231923 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

91
Boster Bio tnf α
The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of <t>CD30L</t> isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.
Tnf α, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tnf α/product/Boster Bio
Average 91 stars, based on 1 article reviews
tnf α - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier

92
Miltenyi Biotec cd30l
Fig. 1. Chicken <t>CD30L</t> cDNA and cloning strategy. Top line represents complete chicken CD30L cDNA. Box represents ORF. Initial fragment was derived from the SSH of LPS-stimulated and non-stimulated spleen cells.
Cd30l, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd30l/product/Miltenyi Biotec
Average 92 stars, based on 1 article reviews
cd30l - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

93
Proteintech 1 ap
Fig. 1. Chicken <t>CD30L</t> cDNA and cloning strategy. Top line represents complete chicken CD30L cDNA. Box represents ORF. Initial fragment was derived from the SSH of LPS-stimulated and non-stimulated spleen cells.
1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/1 ap/product/Proteintech
Average 93 stars, based on 1 article reviews
1 ap - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

90
Boster Bio cd30l antibody
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Cd30l Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd30l antibody/product/Boster Bio
Average 90 stars, based on 1 article reviews
cd30l antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
OriGene human cd30l
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Human Cd30l, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human cd30l/product/OriGene
Average 90 stars, based on 1 article reviews
human cd30l - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

92
Sino Biological hek293 cell line 153
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Hek293 Cell Line 153, supplied by Sino Biological, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hek293 cell line 153/product/Sino Biological
Average 92 stars, based on 1 article reviews
hek293 cell line 153 - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier

90
Federation of European Neuroscience Societies cd30l neoplastic cells
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Cd30l Neoplastic Cells, supplied by Federation of European Neuroscience Societies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd30l neoplastic cells/product/Federation of European Neuroscience Societies
Average 90 stars, based on 1 article reviews
cd30l neoplastic cells - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Amgen monoclonal anti-cd30l antibody m80
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Monoclonal Anti Cd30l Antibody M80, supplied by Amgen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal anti-cd30l antibody m80/product/Amgen
Average 90 stars, based on 1 article reviews
monoclonal anti-cd30l antibody m80 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Immunex Corporation anti-cd30l mab m81
The level of CD30 and <t>CD30L</t> in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.
Anti Cd30l Mab M81, supplied by Immunex Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd30l mab m81/product/Immunex Corporation
Average 90 stars, based on 1 article reviews
anti-cd30l mab m81 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of CD30L isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: The CD30 ligand isoforms have distinct C-terminal extracellular regions. ( A ) Protein alignment of the two isoforms using Clustal Omega. Red—shared intracellular domain; cyan—shared transmembrane domain; purple—shared extracellular domain; black—predicted alpha helix within shared extracellular domain; yellow—extracellular sequences unique to each isoform. Asterisks indicate matching amino acid identity, dots and double dots indicate similarity, and hyphen indicates absence of residues in Iso2. The N-terminus for both proteins is intracellular and identical through residue 136, which includes the transmembrane domain at residues 38–62. The residues following 136 are distinct extracellular C-termini. ( B ) The predicted structural homology of CD30L isoforms to known protein structures generated by the Phyre2 web portal. Iso1 ( left ) showed strong homology to human TNF-alpha with several antiparallel beta-sheets. However, the software did not predict the presence of strong secondary structures for Iso2 ( right ), instead matching homology to small portions of proteins with unstructured domains. The two isoforms did share a predicted alpha helix that was membrane proximal on the extracellular side, present on the left side of each image.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Residue, Generated, Software, Membrane

Both CD30L isoforms were expressed at the RNA level in primary human cells. ( A ) PBMCs were isolated from healthy donors ( n = 6). Cells were either untreated (nt) or stimulated with DMSO, PMA/ionomycin (P/I), lipopolysaccharide (LPS) isolated from E . coli 0111:B4 (LPS), anti-CD3/CD28 beads (CD3/28), or immune complex (IC) for 6 or 24 h. The graphs show actin-normalized expression of both isoforms at both timepoints for all stimulation conditions. Single asterisks indicate p ≤ 0.05 and double asterisks indicate p ≤ 0.01 between the conditions indicated. Error bars represent standard deviation between donors. ( B ) PBMCs were isolated from healthy donors ( n = 3, half of the 6 total donors). Cells were either untreated (nt) or stimulated with PMA/ionomycin (P/I) or immune complex (IC) for 24 h. After incubation, cells were subject to flow cytometry for B cell marker CD19, monocyte marker CD14, and T cell marker CD3, as well as CD30 ligand Iso1. PBMC cell types were present at expected ratios. Error bars are standard deviation between donors.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: Both CD30L isoforms were expressed at the RNA level in primary human cells. ( A ) PBMCs were isolated from healthy donors ( n = 6). Cells were either untreated (nt) or stimulated with DMSO, PMA/ionomycin (P/I), lipopolysaccharide (LPS) isolated from E . coli 0111:B4 (LPS), anti-CD3/CD28 beads (CD3/28), or immune complex (IC) for 6 or 24 h. The graphs show actin-normalized expression of both isoforms at both timepoints for all stimulation conditions. Single asterisks indicate p ≤ 0.05 and double asterisks indicate p ≤ 0.01 between the conditions indicated. Error bars represent standard deviation between donors. ( B ) PBMCs were isolated from healthy donors ( n = 3, half of the 6 total donors). Cells were either untreated (nt) or stimulated with PMA/ionomycin (P/I) or immune complex (IC) for 24 h. After incubation, cells were subject to flow cytometry for B cell marker CD19, monocyte marker CD14, and T cell marker CD3, as well as CD30 ligand Iso1. PBMC cell types were present at expected ratios. Error bars are standard deviation between donors.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Isolation, Expressing, Standard Deviation, Incubation, Flow Cytometry, Marker

Iso2 has a significantly impaired ability to bind CD30 compared to Iso1, but both are present in an exogenous CD30 protein complex. ( A ) HEK cells were transfected with vector (vec) control or FLAG-tagged Iso1 (1FL) or Iso2 (2FL). Lysates and supernatants were subject to a plate-based binding assay with CD30 coated on the plates and anti-FLAG antibody was used for detection. ( B ) Untagged Iso1 (1NT) was transfected into HEK cells with or without FLAG-tagged Iso2 (2FL), as well as 2FL alone. Cell lysates were subject to a plate-based binding assay. An anti-Iso1-specific CD30L antibody was used for capture and an anti-FLAG antibody for detection. ( C ) HEK cells were transfected with increasing amounts of 1NT plasmid, with either vector (vec, undetectable) control or 2FL at a constant amount and lysates were subject to a plate-based binding assay with recombinant CD30 coated on the plates. Anti-FLAG antibody was used for the detection of 2FL. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: Iso2 has a significantly impaired ability to bind CD30 compared to Iso1, but both are present in an exogenous CD30 protein complex. ( A ) HEK cells were transfected with vector (vec) control or FLAG-tagged Iso1 (1FL) or Iso2 (2FL). Lysates and supernatants were subject to a plate-based binding assay with CD30 coated on the plates and anti-FLAG antibody was used for detection. ( B ) Untagged Iso1 (1NT) was transfected into HEK cells with or without FLAG-tagged Iso2 (2FL), as well as 2FL alone. Cell lysates were subject to a plate-based binding assay. An anti-Iso1-specific CD30L antibody was used for capture and an anti-FLAG antibody for detection. ( C ) HEK cells were transfected with increasing amounts of 1NT plasmid, with either vector (vec, undetectable) control or 2FL at a constant amount and lysates were subject to a plate-based binding assay with recombinant CD30 coated on the plates. Anti-FLAG antibody was used for the detection of 2FL. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Transfection, Plasmid Preparation, Binding Assay, Recombinant

Iso1 induces cytokine production in co-culture with CD30+ cells while Iso2 has no effect. Increasing quantities of HEK cells were transfected with either vector (vec) or CD30L isoforms with (FL) or without (NT) FLAG tag. After transfection, K299 cells were co-cultured with HEK cells for 24 h. Supernatants were harvested and subject to cytokine analysis by MSD assay. Error bars for all are from standard deviations between technical replicates.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: Iso1 induces cytokine production in co-culture with CD30+ cells while Iso2 has no effect. Increasing quantities of HEK cells were transfected with either vector (vec) or CD30L isoforms with (FL) or without (NT) FLAG tag. After transfection, K299 cells were co-cultured with HEK cells for 24 h. Supernatants were harvested and subject to cytokine analysis by MSD assay. Error bars for all are from standard deviations between technical replicates.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Co-Culture Assay, Transfection, Plasmid Preparation, FLAG-tag, Cell Culture

Iso2 partially blocks Iso1-mediated stimulation of K299 cells. ( A ) HEK cells were transfected with either vector (vec) control or untagged Iso1 (1NT) with or without untagged Iso2 (2NT) or FLAG-tagged Iso2 (2FL). Transfected HEK cells were co-cultured with a K299-NFkB-Luc reporter clonal line. Two asterisks indicate p ≤ 0.01, three indicate p ≤ 0.001, and four indicate p ≤ 0.0001. ( B , C ) HEK cells were transfected with increasing quantities of 1NT plasmid with either vec or 2NT at a constant quantity, and then co-cultured with the K299-NFkB-Luc reporter line. Reporter activity ( B ) and IL-6 production ( C ) were measured. ( D ) HEK cells were transfected with either 1NT and vec or Iso2 and assessed for 1NT expression by flow cytometry. ( E ) Cells were transfected with increasing quantities of 1NT and either vec or 2FL, and the lysates were subject to SDS-PAGE and Western blot using a pan-CD30L antibody. Densitometry was used to quantify Iso1 bands, normalizing to GAPDH. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: Iso2 partially blocks Iso1-mediated stimulation of K299 cells. ( A ) HEK cells were transfected with either vector (vec) control or untagged Iso1 (1NT) with or without untagged Iso2 (2NT) or FLAG-tagged Iso2 (2FL). Transfected HEK cells were co-cultured with a K299-NFkB-Luc reporter clonal line. Two asterisks indicate p ≤ 0.01, three indicate p ≤ 0.001, and four indicate p ≤ 0.0001. ( B , C ) HEK cells were transfected with increasing quantities of 1NT plasmid with either vec or 2NT at a constant quantity, and then co-cultured with the K299-NFkB-Luc reporter line. Reporter activity ( B ) and IL-6 production ( C ) were measured. ( D ) HEK cells were transfected with either 1NT and vec or Iso2 and assessed for 1NT expression by flow cytometry. ( E ) Cells were transfected with increasing quantities of 1NT and either vec or 2FL, and the lysates were subject to SDS-PAGE and Western blot using a pan-CD30L antibody. Densitometry was used to quantify Iso1 bands, normalizing to GAPDH. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Transfection, Plasmid Preparation, Cell Culture, Activity Assay, Expressing, Flow Cytometry, SDS Page, Western Blot

Iso2 can block Iso1/CD30 interaction and anti-Iso1 antibody binding. ( A ) HEK cells were transfected with increasing quantities of untagged Iso1 (1NT) plasmid with a constant amount of either vector (vec) control or FLAG-tagged Iso2 (2FL). Lysates were used in a plate-based binding assay using CD30 recombinant protein as the capture and an Iso1-specific anti-CD30L antibody was used for detection. ( B ) HEK cells were transfected with 1NT with or without 2FL, and 2FL alone. The lysates were used in a plate-based binding assay using an anti-pan-CD30L antibody for capture and an Iso1-specific anti-CD30L antibody for detection. ( C , D ) HEK cells were transfected with two quantities of 1NT and a constant quantity of 2FL or vector (vec) control in 10 cm plates. Additionally, 10% of the lysates were set aside as the input whole-cell lysate fraction ( C ), and the remainder was incubated with CD30-Fc recombinant protein and protein A/G beads ( D ). Both were subject to SDS-PAGE and Western blot. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Journal: Current Issues in Molecular Biology

Article Title: The Opposite Functions of CD30 Ligand Isoforms

doi: 10.3390/cimb46030172

Figure Lengend Snippet: Iso2 can block Iso1/CD30 interaction and anti-Iso1 antibody binding. ( A ) HEK cells were transfected with increasing quantities of untagged Iso1 (1NT) plasmid with a constant amount of either vector (vec) control or FLAG-tagged Iso2 (2FL). Lysates were used in a plate-based binding assay using CD30 recombinant protein as the capture and an Iso1-specific anti-CD30L antibody was used for detection. ( B ) HEK cells were transfected with 1NT with or without 2FL, and 2FL alone. The lysates were used in a plate-based binding assay using an anti-pan-CD30L antibody for capture and an Iso1-specific anti-CD30L antibody for detection. ( C , D ) HEK cells were transfected with two quantities of 1NT and a constant quantity of 2FL or vector (vec) control in 10 cm plates. Additionally, 10% of the lysates were set aside as the input whole-cell lysate fraction ( C ), and the remainder was incubated with CD30-Fc recombinant protein and protein A/G beads ( D ). Both were subject to SDS-PAGE and Western blot. Error bars for all are from standard deviations between technical replicates; representative experiment of ≥3 shown.

Article Snippet: Clones were tested and chosen for response to CD30L-Fc recombinant protein (Sino Biological 10040-H01H, Wayne, PA, USA) via luciferase assay (described below).

Techniques: Blocking Assay, Binding Assay, Transfection, Plasmid Preparation, Recombinant, Incubation, SDS Page, Western Blot

Fig. 1. Chicken CD30L cDNA and cloning strategy. Top line represents complete chicken CD30L cDNA. Box represents ORF. Initial fragment was derived from the SSH of LPS-stimulated and non-stimulated spleen cells.

Journal: The Journal of veterinary medical science

Article Title: Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL).

doi: 10.1292/jvms.66.643

Figure Lengend Snippet: Fig. 1. Chicken CD30L cDNA and cloning strategy. Top line represents complete chicken CD30L cDNA. Box represents ORF. Initial fragment was derived from the SSH of LPS-stimulated and non-stimulated spleen cells.

Article Snippet: The mRNA expression of CD30L and TRAIL was determined in spleen cells separated using anti-CD3 (Southern Biotechnology Associates, Inc., U.S.A.) and anti-Bu-1ab (kindly supplied by Dr. Vainio) mAbs and Vario MACS (Miltenyi Biotec Heidelberg, Germany) into T- and B-cell fractions.

Techniques: Cloning, Derivative Assay

Fig. 3. Comparison of predicted chicken with human and mouse CD30L amino acid sequences. Signal peptide was marked by arrow. The conserved cysteine and glycosylation sites were showed by block let- ter.

Journal: The Journal of veterinary medical science

Article Title: Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL).

doi: 10.1292/jvms.66.643

Figure Lengend Snippet: Fig. 3. Comparison of predicted chicken with human and mouse CD30L amino acid sequences. Signal peptide was marked by arrow. The conserved cysteine and glycosylation sites were showed by block let- ter.

Article Snippet: The mRNA expression of CD30L and TRAIL was determined in spleen cells separated using anti-CD3 (Southern Biotechnology Associates, Inc., U.S.A.) and anti-Bu-1ab (kindly supplied by Dr. Vainio) mAbs and Vario MACS (Miltenyi Biotec Heidelberg, Germany) into T- and B-cell fractions.

Techniques: Comparison, Glycoproteomics, Blocking Assay

Fig. 5. Expression analysis of chicken CD30L. Expression in various tissues (a), effect of stimulation time on CD30L expression in spleen, thymus, and bursa (b), CD30L expression by spleen T and B cells (c), expression in different cell lines (d) and effec t of stimulation over time on IN24 cell line (e). Poly (A)+ RNA isolated from tissue and cell lines reverse transcribed by RT-PCR using CD30L specific primers (CD30L-RT-F and CD30L-RT-R). Chicken β-actin amplification product was internal control.

Journal: The Journal of veterinary medical science

Article Title: Molecular cloning and characterization of chicken tumor necrosis factor (TNF)-superfamily ligands, CD30L and TNF-related apoptosis inducing ligand (TRAIL).

doi: 10.1292/jvms.66.643

Figure Lengend Snippet: Fig. 5. Expression analysis of chicken CD30L. Expression in various tissues (a), effect of stimulation time on CD30L expression in spleen, thymus, and bursa (b), CD30L expression by spleen T and B cells (c), expression in different cell lines (d) and effec t of stimulation over time on IN24 cell line (e). Poly (A)+ RNA isolated from tissue and cell lines reverse transcribed by RT-PCR using CD30L specific primers (CD30L-RT-F and CD30L-RT-R). Chicken β-actin amplification product was internal control.

Article Snippet: The mRNA expression of CD30L and TRAIL was determined in spleen cells separated using anti-CD3 (Southern Biotechnology Associates, Inc., U.S.A.) and anti-Bu-1ab (kindly supplied by Dr. Vainio) mAbs and Vario MACS (Miltenyi Biotec Heidelberg, Germany) into T- and B-cell fractions.

Techniques: Expressing, Isolation, Reverse Transcription, Reverse Transcription Polymerase Chain Reaction, Amplification, Control

The level of CD30 and CD30L in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.

Journal: BioMed Research International

Article Title: CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling

doi: 10.1155/2018/3261436

Figure Lengend Snippet: The level of CD30 and CD30L in serum from the patients with stable COPD and AECOPD. ((a) and (b)) The level of CD30L and sCD30 in serum from stable COPD and AECOPD and the normal group. Columns, mean of the group; bars, SD. ∗ P < 0.05, normal group versus AECOPD group. # P < 0.05, stable COPD group versus AECOPD group.

Article Snippet: CD30 antibody from Bioss Antibodies (Beijing, China), CD30L antibody purchased from Boster Biological Technology (Wu Han, China).

Techniques:

Immunohistochemical analysis of CD30, CD30L, MMP-9, and VEGF expression in rat models. (A) The expression levels of CD30, CD30L, MMP-9, and VEGF in lung tissues of rat model groups were determined by IHC. CTR: control group; NTR: negative control group. IHC ×200.

Journal: BioMed Research International

Article Title: CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling

doi: 10.1155/2018/3261436

Figure Lengend Snippet: Immunohistochemical analysis of CD30, CD30L, MMP-9, and VEGF expression in rat models. (A) The expression levels of CD30, CD30L, MMP-9, and VEGF in lung tissues of rat model groups were determined by IHC. CTR: control group; NTR: negative control group. IHC ×200.

Article Snippet: CD30 antibody from Bioss Antibodies (Beijing, China), CD30L antibody purchased from Boster Biological Technology (Wu Han, China).

Techniques: Immunohistochemical staining, Expressing, Control, Negative Control